August 27, 2016 3:38 PM ET

Biotechnology

Company Overview of Medgenics, Inc.

Executive Profile

Michael F. Cola

Chief Executive Officer, President and Director, Medgenics, Inc.
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 8 different industries.

See Board Relationships
56$1,882,090
As of Fiscal Year 2015

Background

Mr. Michael F. Cola, also known as Mike, has been the Chief Executive Officer, President and Director of Medgenics, Inc. since September 13, 2013. Mr. Cola served as an Executive Officer at Shire plc since April 2, 2012. Mr. Cola served as the President of Specialty Pharmaceuticals at Shire Limited until April 2012. Mr. Cola served as an Executive Vice President for Global Therapeutic Area Business Units at Shire Limited since July 2005. He was responsible for leading ...

Corporate Headquarters

Building 700
Wayne, Pennsylvania 19087

United States

Phone: 610-254-4201
Fax: --

Board Members Memberships

Director
2007-Present
Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
2012-Present
Independent Director and Member of Audit Committee
2013-Present
Chief Executive Officer, President and Director
2014-Present
Director, Chairman of Nominating & Corporate Governance Committee, Co-Chairman of Science & Technology Committee and Member of Audit Committee

Education

MS
Drexel University
BA
Ursinus College

Other Affiliations

Annual Compensation

Salary$450,000
Bonus$267,750
Total Annual Compensation$717,750

Stocks Options

All Other Compensation$34,840
Exercisable Options$1,184,419
Exercisable Options Value$2,025,009
Unexercisable Options$624,995
Unexercisable Options Value$674,991
Total Value of Options$2,700,000
Total Number of Options$1,809,414

Total Compensation

Total Annual Cash Compensation$752,590
Total Short Term Compensation$717,750
Other Long Term Compensation$34,840
Total Calculated Compensation$1,882,090
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Medgenics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.